title: Comment on "Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice".
authors.affiliation: Department of Neurology, Ulm University, 89081 Ulm, Germany; and.
authors.forename: David
authors.initials: D
authors.lastname: Brenner
authors.affiliation: Department of Neurology, Ulm University, 89081 Ulm, Germany; and Department of Pharmacology and Clinical Neuroscience, Umeå University, 90187 Umeå, Sweden.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Andersen
authors.affiliation: Department of Neurology, Ulm University, 89081 Ulm, Germany; and.
authors.forename: Albert C
authors.initials: AC
authors.lastname: Ludolph
authors.affiliation: Department of Neurology, Ulm University, 89081 Ulm, Germany; and jochen.weishaupt@uni-ulm.de.
authors.forename: Jochen H
authors.initials: JH
authors.lastname: Weishaupt
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000276:immunology*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D047428:Protein Kinase Inhibitors; D007372:Interferons; D017346:Protein Serine-Threonine Kinases